UBAC1

Across TCGA pan-cancer cohorts, UBAC1 mass-spec protein differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of UBAC1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where UBAC1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types UBAC1 is over-expressed in tumor, although a few such as COAD and LUAD show the opposite, repressed pattern.

COAD, LUAD, and HNSC are the cancer types where UBAC1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UBAC1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	III,IV	−0.781	<.001	11	view →
LUAD	Female	III,IV	−1.018	<.001	9	view →
HNSC	Male	IV	−0.824	<.001	8	view →
LSCC	Male	All	−0.743	<.001	8	view →
CCRCC	All	All	+0.227	<.001	6	view →
PDAC	Female	II,III,IV	−0.406	<.001	4	view →
OV	All	All	−0.649	.002	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

UBAC1–COAD

Open the COAD breakdown →